本文来源:时代周报 作者:林昀肖5月以来,中国创新药行业重磅消息不断,A股创新药板块从5月中旬起明显上涨,6月中旬后虽出现回落但较5月以前仍处于高位,多家创新药企业股价也较年初大幅上涨。股价上涨的背后是BD交易的大爆发,据不完全统计,5月以来至少16家国内药企对外官宣BD交易订单,跨境合作占据主流。重磅交易频现伴随资金的大量涌入,熬过四年医药寒冬后,创新药企业是否已步入新的发展阶段?思路迪医药...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.